PUDENZ-SCHULTE MEDICAL RESEARCH CORPORATION – Trademark Portfolio

Entity Type: 03

PUDENZ-SCHULTE MEDICAL RESEARCH CORPORATION holds 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 18 filings in this category. Currently, 3 trademarks are registered. Notable registered marks include DELTA, BIOGLIDE, and PS MEDICAL. The owner is based in GOLETA, CA.

125-B CREMONA DRIVE

GOLETA, CA 93117

18 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

PUDENZ-SCHULTE MEDICAL RESEARCH CORPORATION's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (18 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does PUDENZ-SCHULTE MEDICAL RESEARCH CORPORATION have?

PUDENZ-SCHULTE MEDICAL RESEARCH CORPORATION has 18 U.S. trademarks filed with the USPTO. Of these, 3 registered, 7 abandoned, 8 cancelled.

What trademark classes does PUDENZ-SCHULTE MEDICAL RESEARCH CORPORATION file in?

PUDENZ-SCHULTE MEDICAL RESEARCH CORPORATION files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are PUDENZ-SCHULTE MEDICAL RESEARCH CORPORATION's most well-known trademarks?

PUDENZ-SCHULTE MEDICAL RESEARCH CORPORATION's registered trademark portfolio includes well-known marks such as DELTA, BIOGLIDE, and PS MEDICAL. These are among 3 currently registered trademarks in the portfolio.

What is PUDENZ-SCHULTE MEDICAL RESEARCH CORPORATION's trademark registration success rate?

PUDENZ-SCHULTE MEDICAL RESEARCH CORPORATION has a 17% trademark registration rate, with 3 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.